scispace - formally typeset
R

Robert J. Guo

Researcher at University Health Network

Publications -  7
Citations -  96

Robert J. Guo is an academic researcher from University Health Network. The author has contributed to research in topics: Myeloid leukemia & Population. The author has an hindex of 4, co-authored 7 publications receiving 65 citations. Previous affiliations of Robert J. Guo include University of Ottawa & University of Toronto.

Papers
More filters
Journal ArticleDOI

The Assessment of Competency in Thoracic Sonography (ACTS) scale: validation of a tool for point-of-care ultrasound.

Scott J. Millington, +7 more
- 22 Nov 2017 - 
TL;DR: The results support the conclusion that the ACTS scale is an effective means of making valid judgments regarding competency in point-of-care thoracic ultrasound, and that the majority of learner improvement occurs during their first 25–30 practice studies.
Journal ArticleDOI

Allogeneic hematopoietic cell transplantation may alleviate the negative prognostic impact of monosomal and complex karyotypes on patients with acute myeloid leukemia.

Robert J. Guo, +3 more
- 01 May 2014 - 
TL;DR: The results indicate that neither MK nor CK are high-risk factors in AML patients undergoing allo-HCT and older age and high WBC count were independent prognostic factors for a shorter EFS and a shorter OS.
Journal ArticleDOI

Expert Agreement in the Interpretation of Lung Ultrasound Studies Performed on Mechanically Ventilated Patients.

Scott J. Millington, +7 more
- 01 Nov 2018 - 
TL;DR: Investigating common areas of agreement and disagreement by studying 6 experts as they interpreted lung US studies in a cohort of intensive care unit (ICU) patients found them to be in agreement or disagreement with each other.
Journal ArticleDOI

CD33, not early precursor T-cell phenotype, is associated with adverse outcome in adult T-cell acute lymphoblastic leukaemia.

Robert J. Guo, +6 more
- 01 Mar 2016 - 
TL;DR: The expression pattern of small nucleolar and small Cajal body-specific RNAs characterizes distinct molecular subtypes of multiple myeloma in patients with chronic lymphocytic leukemia.
Journal ArticleDOI

Acute myeloid leukemia with myelodysplasia-related changes diagnosed with multilineage dysplasia alone demonstrates a superior clinical outcome.

Gina Jiang, +7 more
- 13 Aug 2020 - 
TL;DR: AML-MRC-M demonstrates superior clinical outcome compared to the rest of AML, and may be considered not to be classified in the same group as other AML- MRC patients.